Comparison of the Efficacy and Safety of Pemetrexed-Based Versus Paclitaxel-Based Chemotherapy as Third-Line Treatment for Patients with Advanced Breast Cancer
Objective:To compare the efficacy and safety of pemetrexed-based with paclitaxel-based chemotherapy as third-line treatment for patients with advanced breast cancer. Methods: Between January 2009 and February 2016, 109 patients pathologically confirmed with advanced breast cancer in Jiangsu Cancer H...
Main Authors: | Ting QIAN, Xin-en HUANG |
---|---|
Format: | Article |
Language: | English |
Published: |
Third Party Medicine International Publishing Group Co. Limited
2017-06-01
|
Series: | Journal of International Translational Medicine |
Subjects: | |
Online Access: | http://www.jitm.hk/EN/abstract/abstract242.shtml |
Similar Items
-
Erratum on: Chemotherapy in metastatic NSCLC – new regimens (pemetrexed, nab-paclitaxel)
by: Frontiers in Oncology Editorial Office
Published: (2014-10-01) -
Clinical Investigation of Efficacy of Third-line and Beyond Pemetrexed Treatment in Advanced Non-squamous Non-small Cell Lung Cancer
by: Fei YU, et al.
Published: (2012-02-01) -
Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, nab-Paclitaxel)
by: Vera eHirsh, et al.
Published: (2014-07-01) -
Efficacy of Pemetrexed as Second-line Therapy or Beyond in Patients
with Advanced Non-small Cell Lung Cancer
by: Junling LI, et al.
Published: (2012-03-01) -
Comparison of the efficacy and tolerability of gefitinib with pemetrexed maintenance after first-line platinum-based doublet chemotherapy in advanced lung adenocarcinoma: single-center experience
by: Lin L, et al.
Published: (2016-10-01)